MedPath

Inex Pharmaceuticals

Ownership
Private
Employees
-
Market Cap
-
Website
http://www.inexpharm.com

Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
First Posted Date
2003-05-30
Last Posted Date
2013-11-06
Lead Sponsor
Inex Pharmaceuticals
Registration Number
NCT00006383
Locations
🇺🇸

University of Texas Health Center at Tyler, Tyler, Texas, United States

🇨🇦

Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada

🇺🇸

Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

and more 6 locations
© Copyright 2025. All Rights Reserved by MedPath